10-K: Elevance Health 2023 Annual Report: Solid Membership and Revenue Growth Amidst Strategic Reorganization

Elevance Health's 2023 annual report highlights a year of strategic realignment, solid membership, and revenue growth, despite challenges in the Medicaid sector.

Summary

• Elevance Health's 2023 annual report reveals a slight decrease in total medical membership by 1.2%, settling at approximately 47 million members.
• This decline was primarily due to Medicaid attrition following the resumption of eligibility redeterminations and a decrease in Employer Group risk-based business.
• However, the company saw growth in BlueCard, Individual Public Exchange health plans, and Medicare Advantage membership.
• Operating revenue increased by 9.3% to $170.2 billion, driven by higher premium revenues in the Health Benefits segment and growth in CarelonRx pharmacy product revenue.
• Net income rose by 1.7% to $5.991 billion, and diluted earnings per share increased by 3.9% to $25.22.
• The company experienced a reduction in its 2024 Medicare Star ratings, which is expected to negatively impact 2025 operating revenue by approximately $500 million.
• Elevance Health reorganized its reportable segments in 2023 to Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.

Sentiment

Score: 6

Explanation: The document presents a mixed picture. While there is positive revenue growth and strategic realignment, the decrease in medical membership and the reduction in Medicare Star ratings are concerning. The company is taking steps to mitigate the negative impacts, but the overall sentiment is cautiously optimistic.

Positives

• Elevance Health experienced solid growth in operating revenue, driven by premium increases and expansion in the pharmacy business.
• The company's net income and diluted earnings per share showed positive growth year-over-year.
• Elevance Health is expanding its presence in the Individual Public Exchange markets for 2024.
• The company is actively working to mitigate the financial impact of reduced Medicare Star ratings through various strategies.
• Elevance Health continues to enhance interactions with customers, providers, brokers, agents, employees and other stakeholders through digital technology and improvements to internal operations.

Negatives

• Elevance Health experienced a slight decrease in total medical membership, primarily due to Medicaid attrition.
• The company's Medicare Advantage Star ratings decreased for 2024, which is expected to negatively impact 2025 operating revenue.
• The company incurred business optimization charges in the third quarter of 2023, impacting operating expenses.

Risks

• The company faces risks related to accurately predicting and managing healthcare costs, which can impact profitability.
• A significant reduction in enrollment in health benefits programs could adversely affect the company's financial results.
• Cyber-attacks and data security breaches pose a risk to sensitive information and could lead to financial and reputational damage.
• Changes in government regulations and policies, particularly those related to Medicare and Medicaid, could have a material adverse effect on the company's business.
• The company faces intense competition in the managed care industry, which could impact its ability to attract and retain customers.
• The company is subject to risks associated with pandemics, like COVID-19, as well as other extreme events, large-scale medical emergencies and public health crises, which could have a material adverse effect on our business, results of operations, and financial condition and financial performance.

Future Outlook

The company expects to partially mitigate the financial impact of reduced Medicare Star ratings through various strategies such as contract diversification, operating expense efficiencies, capital deployment alternatives and network enhancements. The company also expects continued growth in its Public Exchange membership as Medicaid members who are no longer eligible for Medicaid coverage seek coverage elsewhere.

Management Comments

• The company believes healthcare is local and that they have the strong local presence required to understand and meet local customer needs.
• The company feels that their commitment to health improvement and care management provides added value to customers and healthcare professionals.
• The company believes that practical and sustainable improvements in healthcare must focus on improving healthcare quality while managing costs for total affordability.
• The company expects to continue to rationalize their portfolio of businesses and products and align their investments to optimize their core businesses, invest in high-growth opportunities, and accelerate capabilities and services.

Industry Context

This announcement reflects the ongoing trends in the healthcare industry, including the shift towards value-based care, the increasing importance of digital technology, and the challenges of managing costs and navigating regulatory changes. The company's strategic reorganization and focus on whole-health solutions align with broader industry efforts to improve patient outcomes and reduce healthcare spending.

Comparison to Industry Standards

• Elevance Health's membership numbers place it among the largest health insurers in the United States, comparable to UnitedHealth Group and CVS Health.
• The company's revenue growth is in line with the industry average, but its profitability is impacted by the reduction in Medicare Star ratings.
• The company's focus on digital technology and value-based care is consistent with industry trends, but its success will depend on its ability to execute these strategies effectively.
• The company's expansion in the Public Exchange markets is a strategic move to capture members who are losing Medicaid coverage, similar to other major health insurers.

Management Changes

Legal Proceedings

• The company is involved in ongoing litigation related to the Blue Cross Blue Shield Antitrust Litigation, with the Subscriber Settlement Agreement receiving final approval in August 2022.
• The company is also involved in litigation with Express Scripts, Inc. regarding pharmacy pricing and operational breaches, which was settled in November 2023.
• The company is subject to a civil lawsuit filed by the U.S. Department of Justice alleging false certification of diagnosis data for Medicare risk-adjustment purposes.
• The company is conducting internal investigations of risk-adjustment practices at CareMore and HealthSun, and has self-disclosed these investigations to CMS and the DOJ.

Related Party Transactions

• The company has an equity investment in APC Passe, LLC, from which it assumed premiums.
• The company has a minority interest ownership of Liberty Dental, which provides administrative services to Elevance Health members.

Stakeholder Impact

• Shareholders may be impacted by the reduction in Medicare Star ratings and the resulting decrease in revenue.
• Employees may be affected by the business optimization program, which includes staff reductions and relocation of job functions.
• Customers may experience changes in plan offerings and access to care as the company continues to evolve its business model.
• Providers may be impacted by the company's efforts to implement value-based payment models and improve healthcare quality.
• Suppliers and creditors may be affected by the company's financial performance and strategic decisions.

Next Steps

• The company will continue to implement its strategic plan, focusing on whole-health solutions and digital technology.
• Elevance Health will work to improve its Medicare Star ratings to regain bonus payments and plan level rebates.
• The company will continue to rationalize its portfolio of businesses and products and align its investments to optimize its core businesses, invest in high-growth opportunities, and accelerate capabilities and services.

Key Dates

Keywords

Elevance Health, health insurance, medical membership, operating revenue, Medicare, Medicaid, pharmacy services, healthcare costs, Star ratings, cybersecurity, risk management, digital technology, value-based care